Roche offers free access to diabetes app to relieve pressure on NHSRoche is offering free access to its mySugr Pro diabetes management app in the UK to relieve pressure Share XRoche offers free access to diabetes app to relieve pressure on NHShttps://pharmaphorum.com/news/roche-offers-free-access-to-diabetes-app-during-covid-19/
Sanofi begins trial of Kevzara against COVID-19 complicationsSanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab) in patients hospitalised with severe Share XSanofi begins trial of Kevzara against COVID-19 complicationshttps://pharmaphorum.com/news/sanofi-begins-trial-of-kevzara-against-covid-19-complications/
UK court imposes safety rules on off-label use of Avastin in wet-AMDBayer has said a new UK court ruling could limit off-label use of Roche’s Avastin in ophthalmology by Share XUK court imposes safety rules on off-label use of Avastin in wet-AMDhttps://pharmaphorum.com/news/uk-appeal-court-upholds-use-of-avastin/
Pharma steps up as coronavirus cases soar to 400,000-plusWith the coronavirus pandemic gathering momentum outside China, AstraZeneca has said it will donate 9 million face masks Share XPharma steps up as coronavirus cases soar to 400,000-plushttps://pharmaphorum.com/news/pharma-steps-up-as-coronavirus-cases-soar-to-400000-plus/
New combination trial firms up Venclexta’s prospects in AMLAbbVie and Roche have been thrown a lifeline for their Venclexta drug in acute myeloid leukaemia (AML), just Share XNew combination trial firms up Venclexta’s prospects in AMLhttps://pharmaphorum.com/news/new-combination-trial-firms-up-venclextas-prospects-in-aml/
Large scale tests for coronavirus ‘unfeasible’, says Roche CEOWidespread testing for the coronavirus is still unfeasible, Roche’s CEO Severin Schwan said in a press briefing on Share XLarge scale tests for coronavirus ‘unfeasible’, says Roche CEOhttps://pharmaphorum.com/news/large-scale-tests-for-coronavirus-unfeasible-says-roche-ceo/
Roche begins phase 3 trial of Actemra in COVID-19 pneumoniaRoche is to begin a phase 3 trial of its Actemra/RoActemra as a treatment for patients hospitalised with Share XRoche begins phase 3 trial of Actemra in COVID-19 pneumoniahttps://pharmaphorum.com/news/roche-begins-phase-3-trial-of-actemra-in-covid-19-pneumonia/
Coronavirus to disrupt EU pharma drug launches, analysts warnBig European launches of drugs for cancer, HIV, and sickle cell disease could be affected by coronavirus, according Share XCoronavirus to disrupt EU pharma drug launches, analysts warnhttps://pharmaphorum.com/news/coronavirus-to-disrupt-eu-pharma-drug-launches-analysts-warn/
Janssen antibody could be lung cancer breakthroughThe FDA thinks a dual-target antibody from Janssen could set new standards in treatment for certain patients with Share XJanssen antibody could be lung cancer breakthroughhttps://pharmaphorum.com/news/janssen-genmab-antibody-could-be-lung-cancer-breakthrough/
